US FDA Approves Sanofi Dupixent To Treat Eosinophilic Esophagitis
The Food and Drug Administration (FDA) of the United States has recently approved Dupixent 300 mg produced by Sanofi for the purpose of treating the patients with the eosinophilic esophagitis (EoE) for the people above 12 years and older, which is weighing at least 40 kilograms. With the help of this approval, the Dupixent has […]
Continue Reading